SARS-CoV-2 Vaccine (Affinivax)

N/A

Report date: 2025/03/18 14:23:15

Base Information

Drug NameSARS-CoV-2 Vaccine (Affinivax)
Drug Alias NameSARS-CoV-2 MAPS Vaccine (Affinivax)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAffinivax Inc
China Registration ClassN/A

Develop Information

Active CompaniesAffinivax Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A